24/7 Customer Support
doublle@doubllebio.com
DOUBLLE BIODOUBLLE BIO
  • Home
  • About
    • Corporate Honors
    • Team
  • Product
  • Service
    • Clinical Recruitment
  • News
  • Contact
  • CN
  • Home
  • About
    • Corporate Honors
    • Team
  • Product
  • Service
    • Clinical Recruitment
  • News
  • Contact
  • CN
+86 020 32053707
+86 020 32053707

After taking diabetes medications for so long, why does my blood sugar still keep flu…

2026年11月2日 doublle 2 Comments 29 Views

Many people with diabetes share this puzzle: they take their medication on schedule and don’t even dare to indulge in their diet, yet the numbers on the glucometer still bounce up and down — sometimes...

【Patient Recruitment】Clinical Recruitment for Stem‑Cell Therapy of Type 2 Diabetes Me…

2026年8月24日 doublle No Comment 128 Views

【患者招募】2 型糖尿病干细胞治疗临床招募 【Patient Recruitment】Clinical Rec […]

Enrollment Completed for Doublle Bio hUC-MSCs Phase I Low-Dose Group

2026年3月22日 doublle No Comments 440 Views

The enrollment of the low-dose group in the Phase I clinical trial of Dabao Biological Human Umbilical Cord Mesenchymal Stem Cells has been completed

[Patient Recruitment] Clinical Recruitment for Stem Cell Treatment of Type 2 Diabetes

2026年3月20日 doublle No Comments 440 Views

Phase I clinical study on the safety, tolerability, and preliminary efficacy of E10I stem cell therapy for type 2 diabetes

GuangZhou Doublle Biotech successfully passed the CNAS regular supervision and expans…

2026年3月10日 doublle No Comments 376 Views

The Biological Testing Center of Guangzhou Doublle Biological Products Co., Ltd. has successfully passed the regular supervision review and testing capability expansion review conducted by the China National Accreditation Service for Conformity Assessment (CNAS)

Recent articles

  • After taking diabetes medications for so long, why does my blood sugar still keep flu…
  • 【Patient Recruitment】Clinical Recruitment for Stem‑Cell Therapy of Type 2 Diabetes Me…
  • Enrollment Completed for Doublle Bio hUC-MSCs Phase I Low-Dose Group
  • [Patient Recruitment] Clinical Recruitment for Stem Cell Treatment of Type 2 Diabetes
  • GuangZhou Doublle Biotech successfully passed the CNAS regular supervision and expans…

Recent Comments

No comments yet

Popular posts

Enrollment Completed for Doubl… 22 3 月 26 440 Views
[Patient Recruitment] Clinical… 20 3 月 26 440 Views
GuangZhou Doublle Biotech succ… 10 3 月 26 376 Views
【Patient Recruitment】Clinical… 24 8 月 26 128 Views
After taking diabetes medicati… 02 11 月 26 29 Views

Our Services

E10A 23 7 月 23 0 Views
E10B 23 7 月 23 0 Views
E10H 23 7 月 23 0 Views
E10I 23 7 月 23 0 Views
MSC-Exo 23 7 月 23 0 Views

About Us

The company was founded by Professor Huang Wenlin in 2001, and has been dedicated to the development and transformation of gene engineering technology applications, such as tumor-targeted drug gene therapy and cell therapy.

Our Contact Details

8th Floor, Building B1, Guangzhou Technology Business Accelerator

+86 020 32053707

doublle@doubllebio.com

QR code to contact

Copyright © GuangZhou Doublle Bio | All rights reserved.